Cadherins E and P expression in the molecular types of breast cancer

被引:0
|
作者
Fernandez, Angel
Reigosa, Aldo
Caleiras, Eduardo [1 ]
Saldivia, Felipe [2 ]
Hardisson, David [3 ]
Sanz, Francisco [4 ]
机构
[1] Hosp Metropolitano Norte, Unidad Diagnost Anatomopatol, Valencia, Venezuela
[2] Inst Oncol Dr Miguel Perez Carreno, Valencia, Venezuela
[3] Univ Autonoma Madrid, Fac Med, Dept Anat Patol, E-28049 Madrid, Spain
[4] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain
来源
INVESTIGACION CLINICA | 2015年 / 56卷 / 02期
关键词
cadherin E; cadherin P; molecular class; epithelial-mesenchymal transition; breast cancer; EPITHELIAL-MESENCHYMAL TRANSITION; BASAL-LIKE PHENOTYPE; ESTROGEN-RECEPTOR; TUMOR PROGRESSION; STEM-CELLS; SUBTYPES; CARCINOMA; THERAPY; PROGNOSIS; SURVIVAL;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The epithelial-mesenchymal transition is a process by which tumor cells lose their epithelial markers and migrate to distant organs. This process involves several cell adhesion proteins such as E-cadherin and P-cadherin. The present study was performed in 354 pacients diagnosed with breast infiltrating ductal carcinoma in the Oncology Institute "Dr. Miguel Perez Carrerno", Valencia, Venezuela. The expression of 22 molecules was analyzed by tissue micro-arrays and the results were compared with the molecular clases established by immunohistochemistry, according to the expression of estrogen receptor (ER), progesterone (PR) and human epidermal growth factor receptor type 2 (HER2), and with the overall survival (OS). Based on the results of ER, PR and HER2 molecular classes according to the following percentages were established: Luminal A 42.4%, Luminal B 20.3%, 9% HER2 and 28.2% triple negative (TN). E-cadherin expression was observed conserved in most of the tumors of this series, 92.5% of cases. TN phenotype tumors showed a high percentage (41.7%) with absent or reduced expression. The P-cadherin was expressed in 40.5% of cases, although expressed in all classes; the proportion was significantly higher in cases TN. No significant prognostic value was observed when analyzing the overall five-year survival of patients with tumors with absent or reduced expression of E-cadherin. The P-cadherin expression had a negative relationship with the OS.
引用
收藏
页码:155 / 168
页数:14
相关论文
共 50 条
  • [1] Subclassification of the molecular types of breast cancer based on the expression of immunohistochemical markers and evolution
    Reigosa, Aldo
    Hardisson, David
    Sanz, Francisco
    Caleiras, Eduardo
    Saldivia, Felipe
    Fernandez, Angel
    INVESTIGACION CLINICA, 2016, 57 (02): : 187 - 216
  • [2] Microvessel Density and Mammaglobin A Expression as Prognostic Markers in Molecular Types of Breast Cancer
    Jitariu, Adriana Andreea
    Ceausu, Amalia Raluca
    Meche, Adriana
    Nica, Cristian
    Burlea, Amelia
    Raica, Marius
    REVISTA DE CHIMIE, 2019, 70 (07): : 2671 - 2676
  • [3] Molecular mechanisms controlling E-cadherin expression in breast cancer
    Baranwal, Somesh
    Alahari, Suresh K.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 384 (01) : 6 - 11
  • [4] Impact of chemotherapy on the expression of claudins and cadherins in invasive breast cancer
    Skalova, Helena
    Hajkova, Nikola
    Majerova, Barbora
    Bartu, Michaela
    Povysil, Ctibor
    Ticha, Ivana
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (04) : 3014 - 3024
  • [5] Cadherins: The Superfamily Critically Involved in Breast Cancer
    Ashaie, Maeirah Afzal
    Chowdhury, Ezharul Hoque
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (05) : 616 - 638
  • [6] Differential Expression of E- Cadherin and P-Cadherin in Breast Cancer Molecular Subtypes
    Margan, Madalin Marius
    Cimpean, Anca Maria
    Ceausu, Amalia Raluca
    Raica, Marius
    ANTICANCER RESEARCH, 2020, 40 (10) : 5557 - 5566
  • [7] Clinical implications of β-catenin protein expression in breast cancer
    Wang, Ziyi
    Zhang, Hao
    Hou, Jianxin
    Niu, Jianing
    Ma, Zhenhai
    Zhao, Haidong
    Liu, Caigang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 14989 - 14994
  • [8] Expression of EMT Markers SLUG and TWIST in Breast Cancer
    Grzegrzolka, Jedrzej
    Biala, Martyna
    Wojtyra, Patrycja
    Kobierzycki, Christopher
    Olbromski, Mateusz
    Gomulkiewicz, Agnieszka
    Piotrowska, Aleksandra
    Rys, Janusz
    Podhorska-Okolow, Marzena
    Dziegiel, Piotr
    ANTICANCER RESEARCH, 2015, 35 (07) : 3961 - 3968
  • [9] E-cadherin expression in molecular types of breast carcinoma
    Popescu, Carmen Ionescu
    Giusca, Simona Eliza
    Liliac, Ludmila
    Avadanei, Roxana
    Ceausu, Raluca
    Cimpean, Anca Maria
    Balan, Raluca
    Amalinei, Cornelia
    Apostol, Delta Ciobanu
    Caruntu, Irina-Draga
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2013, 54 (02) : 267 - 273
  • [10] Cytokeratin and vimentin expression in breast cancer
    Vora, Hemangini H.
    Patel, Nupur A.
    Rajvik, Kruti N.
    Mehta, Shalvi V.
    Brahmbhatt, Birwa V.
    Shah, Manoj J.
    Shukla, Shilin N.
    Shah, Pankaj M.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2009, 24 (01) : 38 - 46